ICD-10 Code for Rectal Cancer: Complete Medical Coding Guide

A physician may document rectal cancer and the diagnosis may seem uncomplicated. However, in the real-world of medical coding and billing, the correct ICD-10 number to use for rectal cancer will depend on the provider’s documentation, whether the malignancy is current or historical, if there is metastatic illness, the type of tumor treated, and the purpose for the encounter. This difference significant because diagnosis coding supports medical necessity and helps link the clinical record to the services recorded on the claim.

When the diagnosis does not match the record or the service that is being charged for the claim can be hard to challenge. Wrong coding depending on the situation can cause claim rejections, changes based on need not coding enough coding too much payments that are late incorrect payments questions about the records and chances of being checked in an audit. Cases involving cancer can also involve many different services such, as diagnostic colonoscopy, biopsy, pathology, imaging, chemotherapy, radiation therapy, surgery and checking after treatment.

This guide covers the common ICD-10-CM codes for rectal cancer and related conditions. It explains how to tell the difference, between secondary malignancies. You will also find CPT and HCPCS codes that come up in rectal cancer care. The guide includes documentation rules how to sequence codes and real-world billing examples to help with practical use.

What Is the ICD-10 Code for Rectal Cancer?

The main ICD‑10‑CM code, for cancer is C20 – Malignant neoplasm of rectum. If the provider writes that the patient has a malignant neoplasm of the rectum then the ICD‑10‑CM code C20 should be used. The CMS ICD‑10‑CM code system also puts tumors of the rectum under the ICD‑10‑CM code C20.

However, C20 is not necessarily suitable for each tumor in or near the rectum. Documentation may differ if the rectosigmoid junction, anus or anal canal, secondary malignant location, malignant carcinoid/neuroendocrine tumor, gastrointestinal stromal tumor, carcinoma in situ, benign neoplasm, or personal history of malignancy is included in the documentation.

For example:

Clinical documentation	Common ICD-10-CM code
Primary malignant neoplasm of rectum	C20
Malignant neoplasm of rectosigmoid junction	C19
Malignant neoplasm of overlapping sites of rectum, anus and anal canal	C21.8
Carcinoma in situ of rectum	D01.2
Benign neoplasm of rectum	D12.8
Malignant carcinoid tumor of rectum	C7A.026
Benign carcinoid tumor of rectum	D3A.026
Secondary malignant neoplasm of large intestine and rectum	C78.5
Personal history of other malignant neoplasm of rectum, rectosigmoid junction and anus	Z85.048
Encounter for follow-up after completed cancer treatment	Z08
Encounter for antineoplastic chemotherapy	Z51.11
Encounter for antineoplastic radiation therapy	Z51.0

The alternatives show why coders should not call a case rectal cancer just because the word “rectal” is found in the clinical report. The provider’s recorded diagnosis and applicable ICD-10-CM instructions guide code selection. CMS materials segregate C19, C20, C21.8, C7A.026, D01.2, D12.8 and similar categories.

Rectal Cancer ICD-10-CM Code Reference Table

The following table brings together the diagnosis codes that are particularly relevant when coding and billing patients with suspected, confirmed, active, metastatic, treated, or historical rectal malignancy.

Condition or billing scenario	ICD-10-CM code	Description / coding use
Primary rectal cancer	C20	Malignant neoplasm of rectum
Rectosigmoid cancer	C19	Malignant neoplasm of rectosigmoid junction
Overlapping rectal/anal/anal-canal malignancy	C21.8	Malignant neoplasm of overlapping sites of rectum, anus and anal canal
Malignant carcinoid/neuroendocrine tumor of rectum	C7A.026	Malignant carcinoid tumor of rectum
Secondary malignant neoplasm involving large intestine/rectum	C78.5	Secondary malignant neoplasm of large intestine and rectum
Secondary intrapelvic lymph-node malignancy	C77.5	Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes
Secondary intra-abdominal lymph-node malignancy	C77.2	Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
Secondary lung malignancy	C78.00–C78.02	Secondary malignant neoplasm of lung, with laterality where applicable
Secondary peritoneal/retroperitoneal malignancy	C78.6	Secondary malignant neoplasm of retroperitoneum and peritoneum
Secondary liver malignancy	C78.7	Secondary malignant neoplasm of liver and intrahepatic bile duct
Secondary bone malignancy	C79.51	Secondary malignant neoplasm of bone
Disseminated malignant neoplasm	C80.0	Disseminated malignant neoplasm, unspecified
Malignant neoplasm without specified primary site	C80.1	Malignant (primary) neoplasm, unspecified
Carcinoma in situ of rectum	D01.2	Carcinoma in situ of rectum
Benign neoplasm of rectum	D12.8	Benign neoplasm of rectum
Benign carcinoid tumor of rectum	D3A.026	Benign carcinoid tumor of rectum
Personal history of malignant rectal/rectosigmoid/anal cancer	Z85.048	Personal history of other malignant neoplasm of rectum, rectosigmoid junction and anus
Personal history of malignant carcinoid tumor of rectum	Z85.040	Personal history of malignant carcinoid tumor of rectum
Follow-up after completed cancer treatment	Z08	Encounter for follow-up examination after completed treatment for malignant neoplasm
Chemotherapy encounter	Z51.11	Encounter for antineoplastic chemotherapy
Immunotherapy encounter	Z51.12	Encounter for antineoplastic immunotherapy
Radiation therapy encounter	Z51.0	Encounter for antineoplastic radiation therapy
Rectal cancer screening	Z12.12	Encounter for screening for malignant neoplasm of rectum
Colon cancer screening	Z12.11	Encounter for screening for malignant neoplasm of colon
Hemorrhage of anus/rectum	K62.5	May be relevant when documented as the reason for a diagnostic encounter
Change in bowel habit	R19.4	Symptom diagnosis when documented and applicable
Other fecal abnormalities	R19.5	Symptom/sign code
Diarrhea, unspecified	R19.7	Symptom diagnosis
Abnormal digestive-tract imaging finding	R93.3	Abnormal findings on diagnostic imaging of other digestive tract

CMS coding and billing materials separately identify many of these malignancy, neoplasm, history, screening, and symptom categories.

Why C20 and C19 Should Not Be Interchanged

The most frequent area of concern is the difference between the rectum and the rectosigmoid junction.

When the provider writes down that there is a malignant tumor in the rectum the code C20 is usually the right diagnosis code. If the information says that the tumor starts at the rectosigmoid junction then the right category is C19.

The coder should not decide by themselves where a tumor that is on the edge of two areas must be located because of what the imaging says or what they think. If the notes do not clearly show the place needed to pick the right code then asking the provider a question, in a way might be the right step.

How to Select the Correct ICD-10 Code for Rectal Cancer

Correct coding begins with the medical record, not with the claim form.

1. Start With the Provider’s Documented Diagnosis

Look first for the assessment, impression, operative diagnosis, pathology interpretation as incorporated into the provider’s diagnosis, oncology assessment, and other relevant provider documentation.

A coder should not independently diagnose rectal cancer from a CT scan, MRI, colonoscopy appearance, elevated tumor marker, or symptoms.

For example:

Colonoscopy identifies a suspicious rectal mass.

That statement does not necessarily mean the coder should independently assign C20 as confirmed rectal cancer. The final diagnosis and applicable outpatient or inpatient coding rules must be considered.

If the provider documents:

Adenocarcinoma of the rectum.

then C20 is generally the relevant primary-site diagnosis.

2. Confirm the Anatomic Site

Determine whether the documentation identifies:

• Rectum
• Rectosigmoid junction
• Colon
• Anus
• Anal canal
• Overlapping sites
• Another organ with secondary involvement of the rectum

This distinction is particularly important in colorectal oncology because adjacent anatomical sites have separate ICD-10-CM categories.

3. Determine Whether the Malignancy Is Primary or Secondary

Primary rectal malignancy is one of the neoplasms of the rectum . Metastatic involvement of the rectum from other primary tumors is also seen .

For example, C20 means malignant tumor of the rectum and C78.5 means secondary malignant neoplasm of the large intestine and rectum.

Do not presume that a malignant lesion in the rectum is a primary colorectal cancer.

4. Determine the Tumor Type When the Documentation Requires a Different Code Category

Most conventional rectal adenocarcinomas are coded to the malignant neoplasm site category when documented as a primary rectal malignancy.

Certain specialized tumor types have separate classifications. For example, CMS materials distinguish malignant carcinoid tumor of the rectum, C7A.026, from C20.

Likewise, a benign rectal neoplasm is not coded as active malignant rectal cancer.

5. Establish Whether the Cancer Is Active or Historical

This distinction can significantly affect both diagnosis coding and medical necessity.

If the patient is currently receiving treatment for active rectal cancer, the active malignancy code may be appropriate.

If treatment has been completed and the patient is being monitored without current malignancy, a personal-history code may be appropriate when supported by the record.

For rectal, rectosigmoid-junction, and anal malignancy history, CMS lists Z85.048 for personal history of other malignant neoplasm of those sites.

Do not automatically replace an active malignancy with a history code simply because surgery has occurred. Review the complete clinical situation and the current provider documentation.

6. Look for Metastatic Disease

Rectal cancer may be documented with secondary disease involving lymph nodes, liver, lungs, peritoneum, bone, or other sites.

Examples include:

• C77.5 — secondary and unspecified malignant neoplasm of intrapelvic lymph nodes
• C77.2 — secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes
• C78.5 — secondary malignant neoplasm of large intestine and rectum
• C78.6 — secondary malignant neoplasm of retroperitoneum and peritoneum
• C78.7 — secondary malignant neoplasm of liver and intrahepatic bile duct
• C79.51 — secondary malignant neoplasm of bone

CMS identifies these as separate secondary malignant-neoplasm categories.

7. Determine the Reason for the Encounter

The same patient may legitimately have different sequencing depending on why the encounter occurred.

For example:

Active treatment of rectal cancer. When treatment is aimed to the main malignancy, the malignancy may be listed as the primary or first-listed diagnosis.

Chemotherapy encounter: When the encounter is for the administration of antineoplastic chemotherapy, the ICD-10-CM rules state Z51.11 should be used as the first-listed/principal diagnosis, and the malignancy should be recorded as an extra diagnosis, where appropriate.

Radiation encounter Z51.0 may be sequenced first if the encounter is principally for radiation therapy for neoplastic disease (including reporting the malignancy).

Chemotherapy, Immunotherapy, and Radiation Therapy Encounters Sequencing Special coverage in the FY 2026 Official Guidelines.

8. Review the Tabular List and Instructional Notes

Never rely solely on a search result or encoder display.

After locating a code in the Alphabetic Index, verify the code in the Tabular List and review:

• Includes notes
• Excludes1 notes
• Excludes2 notes
• Code first instructions
• Use additional code instructions
• Laterality requirements where applicable
• Site-specific instructions
• Current-year changes

The Official Guidelines emphasize that the classification’s conventions and instructions take precedence and that the entire record should be reviewed to determine the reason for the encounter and conditions treated.

CPT and HCPCS Codes Commonly Associated With Rectal Cancer Billing

There is not one CPT code for rectal cancer. ICD-10-CM generally describes the diagnosis, while CPT and HCPCS codes describe many of the professional services, procedures, drugs, and other billable services associated with evaluation and treatment.

The correct CPT code depends on what the provider actually performed.

Diagnostic and Endoscopic Services

Commonly encountered CPT codes include:

CPT/HCPCS	Common use in rectal-cancer care
45330	Flexible sigmoidoscopy, diagnostic
45331	Flexible sigmoidoscopy with biopsy
45332	Flexible sigmoidoscopy with removal of lesion by techniques specified in the code
45333	Flexible sigmoidoscopy with removal of tumor/polyp/lesion by snare
45334	Flexible sigmoidoscopy with removal by hot biopsy forceps or bipolar cautery
45335	Flexible sigmoidoscopy with submucosal injection
45338	Flexible sigmoidoscopy with control of bleeding
45378	Diagnostic colonoscopy
45380	Colonoscopy with biopsy
45381	Colonoscopy with submucosal injection
45382	Colonoscopy with control of bleeding
45384	Colonoscopy with removal by hot biopsy forceps or bipolar cautery
45385	Colonoscopy with removal by snare technique
45388	Colonoscopy with ablation of tumor/polyp/lesion

CMS documents identify 45330 and 45378 as diagnostic endoscopic services and include 45380 and 45385 as regularly used colonoscopy procedure codes.

The provider should use the latest CPT code set to choose the code that matches the operation documented. It can be a different CPT code for a biopsy, snare removal, injection or bleeding-control service or ablation.

A Key Billing Issue: 45380 and 45385

CMS has specifically discussed the relationship between 45380 and 45385 under NCCI-associated modifier guidance.

Modifier 59 should not be included simply because two separate procedures were conducted. CMS says modifier 59 may be acceptable when the procedures are conducted on different lesions, different anatomic areas, different encounters, or under other conditions that meet the requirements for the modifier. This difference must be documented.

For example, if one lesion is biopsied and a distinct lesion is snared, documentation may allow reporting both procedures when all applicable coding and NCCI standards are completed. Modifier 59 cannot be assumed acceptable only based on a different diagnosis code.

Screening Versus Diagnostic Colonoscopy

This distinction is particularly important for colorectal cancer billing.

A screening encounter is not categorized the same as an encounter undertaken because the patient has symptoms, an abnormal test, known cancer, or other clinical indication.

Z12.11 – Encounter for screening for malignant neoplasm of colon. Z12.12 – Encounter for screening for malignant neoplasm of rectum. (CMS)

When a screening procedure results in discovery and removal of a lesion, additional rules can apply. CMS has published examples addressing screening colonoscopy claims that become diagnostic or therapeutic when a lesion is discovered.

Billing teams should therefore review the original intent of the encounter, the procedure actually performed, applicable CPT modifiers, payer rules, and the documentation.

Surgical CPT Coding for Rectal Cancer

Rectal cancer treatment can involve local excision, transanal procedures, proctectomy, low anterior resection, abdominoperineal procedures, colorectal anastomosis, ostomy creation, lymph-node work, and other services.

Surgical CPT coding is highly dependent on the operative report.

For example, CMS data identify colorectal surgical codes such as:

• 44140 — partial colectomy with anastomosis
• 44143 — partial colectomy with end colostomy and closure of the distal segment
• 44145 — partial colectomy with coloproctostomy
• 44204 — laparoscopic partial colectomy with anastomosis
• 44207 — laparoscopic partial colectomy with coloproctostomy/low pelvic anastomosis

These examples demonstrate why a coder should not select a surgical CPT code solely from a diagnosis of “rectal cancer.” The operative approach, anatomy removed, reconstruction, anastomosis, ostomy, and other documented components determine the appropriate procedure code.

For complex rectal procedures, the current CPT codebook and operative report should be reviewed rather than relying on a generic online code list.

Radiation and Chemotherapy Billing

Rectal cancer treatment may involve radiation therapy, systemic chemotherapy, immunotherapy, or combinations of these services.

For radiation therapy, commonly encountered CPT/HCPCS reporting can involve treatment planning, treatment delivery, image guidance, and treatment management. CMS data, for example, identify 77427 for radiation treatment management and other radiation planning and delivery codes.

The exact radiation codes depend on the modality and service performed.

For chemotherapy and immunotherapy, the claim can involve:

• Drug HCPCS codes
• Drug units
• Administration CPT codes
• Infusion start/stop times where required
• Route of administration
• Sequential or concurrent administration
• Medical necessity diagnosis coding
• Payer-specific coverage requirements

The diagnosis and administration coding should correspond to the actual encounter. When an encounter is chiefly for chemotherapy, the ICD-10-CM Official Guidelines identify Z51.11 as the first-listed/principal diagnosis, with the malignancy reported additionally as appropriate. For immunotherapy, Z51.12 applies; for antineoplastic radiation therapy, Z51.0 applies.

Pathology and Laboratory Services

A rectal mass frequently generates pathology services following biopsy or surgical excision.

Depending on the specimen and service, pathology billing may involve surgical pathology CPT codes and ancillary testing. The exact pathology code depends on the specimen, level of service, special studies, immunohistochemistry, molecular testing, and other documented work.

The diagnosis attached to the pathology claim should accurately describe the clinical indication or established condition according to the applicable coding and payer requirements.

This is another reason not to use C20 automatically for every biopsy of a rectal lesion. A biopsy performed because of rectal bleeding, an abnormal imaging finding, or a suspected lesion may have a different diagnosis context before malignancy is established.

Documentation Checklist for Rectal Cancer Coding

Good documentation makes accurate coding much easier. It also helps the billing team demonstrate why the service was medically necessary.

Documentation element	What the record should clarify
Primary diagnosis	Whether the provider diagnoses rectal malignancy
Anatomic site	Rectum, rectosigmoid junction, anus, anal canal, or another site
Histology/type	Adenocarcinoma, neuroendocrine/carcinoid tumor, other documented tumor type
Disease status	Active malignancy, treated disease, remission/history as clinically documented
Metastatic disease	Documented secondary sites and lymph-node involvement
Reason for encounter	Diagnosis, treatment, surveillance, chemotherapy, radiation, symptoms, or follow-up
Treatment	Surgery, chemotherapy, immunotherapy, radiation, or other treatment
Procedure	Exact procedure performed and anatomical site
Operative details	Approach, excision/resection, anastomosis, ostomy and other relevant components
Endoscopy	Extent of examination and intervention performed
Biopsy	Site and number/type of specimens when relevant
Pathology	Final diagnostic information incorporated into provider documentation
Complications	Documented obstruction, bleeding, perforation, infection, or other conditions
History	Prior rectal/colorectal malignancy and treatment history
Surveillance	Reason for follow-up or post-treatment examination

The FY 2026 Official Guidelines emphasize the importance of complete documentation and state that accurate coding depends on reviewing the entire record and identifying the reason for the encounter and conditions treated.

Common ICD-10 Coding Mistakes With Rectal Cancer

Mistake 1: Using C20 for Every Rectal Lesion

A rectal polyp, benign neoplasm, carcinoma in situ, malignant carcinoid tumor, and primary adenocarcinoma are not necessarily represented by the same code.

The documentation must establish the condition.

Mistake 2: Coding a History of Cancer as Active Cancer

A patient who previously had rectal cancer does not automatically have active C20 disease forever.

When treatment has been completed and the malignancy is no longer current, the applicable history and follow-up codes may be more appropriate. CMS lists Z08 for follow-up after completed treatment and Z85.048 for personal history of other malignant neoplasm involving the rectum, rectosigmoid junction, and anus.

Mistake 3: Ignoring Secondary Malignancies

If metastatic disease is documented, the secondary sites may require additional ICD-10-CM codes.

For example, liver metastasis and intrapelvic lymph-node metastasis are represented by different categories than the primary rectal malignancy.

Mistake 4: Confusing Screening With Diagnostic Testing

A screening colonoscopy is done in an asymptomatic person to screen for cancer. A colonoscopy prompted by rectal bleeding, an abnormal study, known cancer, or another clinical indication has a different coding context.

CMS recognizes specifically Z12.11 and Z12.12 as screening diagnoses and has billing guidance for screening procedures that evolve into a diagnostic or therapeutic procedure.

Mistake 5: Selecting CPT From the Diagnosis

ICD-10-CM answers the diagnosis question. CPT generally describes the professional service or procedure.

“Rectal cancer” does not by itself determine whether the procedure was a colonoscopy with biopsy, snare removal, sigmoidoscopy, radiation management, surgical resection, or another service.

The procedure documentation determines the CPT code.

Mistake 6: Using Modifier 59 Without Documentation

Modifier 59 is not a general-purpose solution for obtaining separate payment.

CMS explains that NCCI-associated modifiers require the circumstances to support separate reporting, such as different lesions, anatomical sites, or encounters when applicable.

How ICD-10, CPT, HCPCS and Modifiers Work Together

A clean rectal cancer claim usually requires several pieces of information to line up.

ICD-10-CM answers:

What condition, disease, symptom, history, or reason for encounter is being reported?

CPT answers:

What professional procedure or service was performed?

HCPCS Level II may answer:

What drug, supply, equipment, service, or other item is being reported?

Modifiers provide additional information about the service when the applicable coding rules permit their use.

For example, a patient may have:

ICD-10-CM: C20 — primary rectal malignancy

CPT: 45380 — colonoscopy with biopsy

Pathology: separately reported according to the specimen and pathology services performed

The diagnosis does not automatically determine the CPT code. The procedure report must support the CPT code.

Likewise, a patient receiving chemotherapy may have an encounter diagnosis involving Z51.11 plus the active malignancy and separately reported drug and administration services, subject to the applicable payer rules.

Medical Necessity and Payer Considerations

A diagnosis code can be technically valid but still fail to support a particular service under a payer’s coverage policy.

For rectal cancer claims, billing teams should check:

• Medicare National Coverage Determinations
• Local Coverage Determinations
• Medicare Administrative Contractor billing articles
• Commercial payer medical policies
• Prior authorization requirements
• NCCI procedure-to-procedure edits
• Diagnosis-to-procedure medical-necessity edits
• Frequency limitations
• Modifier requirements
• Site-of-service rules
• Drug authorization and unit requirements
• Documentation requirements

CMS maintains coverage and billing resources that contain procedure-specific diagnosis lists and coding instructions. For example, CMS colonoscopy materials include diagnosis categories covering active and historical colorectal malignancy, symptoms, screening, and other gastrointestinal conditions.

A practice should not assume that one diagnosis code guarantees coverage for every service related to rectal cancer.

Practical Workflow for Medical Billing Teams

A useful rectal cancer billing workflow is:

Provider documentation → Diagnosis verification → ICD-10-CM assignment → Procedure verification → CPT/HCPCS assignment → NCCI/edit review → Medical-necessity review → Modifier review → Claim submission → Denial/ERA review

Before submitting the claim, verify that:

1. The diagnosis is supported by provider documentation.
2. The primary site is correctly identified.
3. Active cancer is not confused with historical cancer.
4. Metastatic sites are coded when applicable.
5. The reason for the encounter is clear.
6. The CPT code matches the actual service performed.
7. The operative or endoscopy report supports the procedure.
8. Modifiers are supported by documentation.
9. Drug and infusion units are accurate when applicable.
10. The payer’s medical-necessity requirements have been checked.
11. The code set corresponds to the date of service.
12. NCCI and other applicable claim edits have been reviewed.

This workflow can reduce avoidable discrepancies between the clinical note, coding record, and claim.

Final Takeaway

The ICD-10 code for rectal cancer is C20 when documentation establishes a primary malignant neoplasm of the rectum, but accurate medical coding rarely ends with one code. The coder must distinguish rectal cancer from rectosigmoid cancer, anal malignancy, secondary malignant disease, carcinoma in situ, benign neoplasms, specialized neuroendocrine tumors, and personal history of cancer.

For billing purposes, the diagnosis must also align with the service being reported. Colonoscopy and biopsy procedures may use CPT codes such as 45378 and 45380, while snare removal may involve 45385; surgical, radiation, pathology, chemotherapy, and drug-related services require their own procedure and HCPCS reporting based on what was actually performed. CMS guidance also makes encounter sequencing important, particularly for chemotherapy, radiation, follow-up, and other cancer-related services.

The safest approach is to begin with the provider’s documentation, identify the exact anatomical site and disease status, determine whether the malignancy is primary or secondary, establish the reason for the encounter, verify the current ICD-10-CM and CPT/HCPCS versions, review applicable instructional notes and payer policies, and then ensure that the claim accurately reflects the services documented.

For healthcare providers, coders, billers, and practice administrators, that documentation-to-coding connection is what makes a rectal cancer claim both clinically supportable and defensible during payer review or audit.

Frequently Asked Questions About ICD-10 Code for Rectal Cancer

What is the ICD-10 code for rectal cancer?

The principal ICD-10-CM code for a documented primary malignant neoplasm of the rectum is C20.

What is the ICD-10 code for rectal adenocarcinoma?

When the provider documents primary adenocarcinoma of the rectum, C20 is generally the site-based ICD-10-CM code for the malignant neoplasm of the rectum, unless documentation or classification instructions indicate a different code category.

What is the ICD-10 code for rectal cancer screening?

Z12.12 is used for an encounter for screening for malignant neoplasm of the rectum. CMS colorectal screening materials also distinguish Z12.11 for colon screening.

What is the ICD-10 code for personal history of rectal cancer?

For a personal history of other malignant neoplasm of the rectum, rectosigmoid junction, and anus, CMS lists Z85.048.

What is the ICD-10 code for secondary malignant neoplasm of the rectum?

C78.5 identifies secondary malignant neoplasm of the large intestine and rectum. It should not be substituted for C20 when the documentation establishes a primary rectal malignancy.

What is the ICD-10 code for carcinoma in situ of the rectum?

D01.2 identifies carcinoma in situ of the rectum.

What is the ICD-10 code for a benign rectal tumor?

D12.8 identifies benign neoplasm of the rectum.

Is there a CPT code specifically for rectal cancer?

No single CPT code represents “rectal cancer.” CPT selection depends on the service performed, such as diagnostic colonoscopy, biopsy, lesion removal, surgery, radiation treatment management, or another procedure.

What CPT codes are commonly used for rectal cancer diagnosis?

Depending on the procedure, commonly encountered codes include 45330 for diagnostic flexible sigmoidoscopy, 45378 for diagnostic colonoscopy, 45380 for colonoscopy with biopsy, and 45385 for colonoscopy with snare removal. The current CPT code set and procedure documentation should always be checked.

When is Z51.11 used with rectal cancer?

When the encounter is chiefly for administration of antineoplastic chemotherapy, ICD-10-CM guidelines direct use of Z51.11 as the first-listed/principal diagnosis, with the malignancy additionally reported as appropriate.

Can a coder assign C20 from a suspicious rectal mass?

A coder should not independently diagnose malignancy from a suspicious mass, imaging, laboratory result, or endoscopic appearance. The appropriate code depends on the provider’s documented diagnosis and the applicable coding guidelines.